SYSTEMIC SCLEROSIS
Clinical trials for SYSTEMIC SCLEROSIS explained in plain language.
Never miss a new study
Get alerted when new SYSTEMIC SCLEROSIS trials appear
Sign up with your email to follow new studies for SYSTEMIC SCLEROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Early intervention trial for lung blood vessel disease halted
Disease control TerminatedThis study aimed to see if a drug called riociguat could help control early-stage pulmonary vascular disease, a condition that can lead to high blood pressure in the lungs. It involved 35 adults with connective tissue diseases like systemic sclerosis who showed early signs of the…
Matched conditions: SYSTEMIC SCLEROSIS
Phase: PHASE2 • Sponsor: Heidelberg University • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
Researchers halt small study aimed at Fine-Tuning scleroderma treatment
Knowledge-focused TerminatedThis study aimed to find the best blood level of the drug mycophenolate mofetil (MMF) to treat skin thickening and lung problems in people with systemic sclerosis (scleroderma). It was an observational study that planned to follow patients for one year to see if specific drug lev…
Matched conditions: SYSTEMIC SCLEROSIS
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC